Jessica Gold1, Patricia Hametz2, Anita I Sen3, Philip Maykowski4, Nicole Leone5, Diana S Lee2, Christina Gagliardo6, Saul Hymes7, Rachel Biller8, Lisa Saiman3,9. 1. Morgan Stanley Children's Hospital, Columbia University Medical Center and jgold2@stanford.edu. 2. Children's Hospital at Montefiore and Albert Einstein College of Medicine, Bronx, New York. 3. Morgan Stanley Children's Hospital, Columbia University Medical Center and. 4. College of Medicine-Phoenix, University of Arizona, Phoenix, Arizona. 5. Cohen Children's Medical Center, Northwell Health, Queens, New York. 6. Goryeb Children's Hospital, Morristown Medical Center, Morristown, New Jersey. 7. Department of Pediatrics, Stony Brook Children's Hospital, Stony Brook, New York; and. 8. Department of Pediatrics, Maria Fareri Children's Hospital, Westchester Medical Center, Valhalla, New York. 9. Department of Infection Prevention and Control, New York-Presbyterian Hospital, New York City, New York.
Abstract
BACKGROUND AND OBJECTIVES: Practice guidelines have been published for bronchiolitis and community-acquired pneumonia (CAP), but little is known about pediatricians' knowledge of and attitudes toward these guidelines since their publication. METHODS: We surveyed pediatric providers at 6 children's hospitals in the New York City area. Two vignettes, an infant with bronchiolitis and a child with CAP, were provided, and respondents were asked about management. Associations between respondent characteristics and their reported practices were examined using χ2 and Fisher's exact tests. Associations between questions probing knowledge and attitude barriers relevant to guideline adherence and reported practices were examined using Cochran-Mantel-Haenszel relative risk estimates. RESULTS: Of 283 respondents, 58% were trainees; 57% of attending physician respondents had finished training within 10 years. Overall, 76% and 45% of respondents reported they had read the bronchiolitis and CAP guidelines, respectively. For the bronchiolitis vignette, 40% reported ordering a chest radiograph (CXR), and 38% prescribed bronchodilators (neither recommended). For the CAP vignette, 38% prescribed ceftriaxone (not recommended). Study site, level of training, and practice locations were associated with nonrecommended practices. Site-adjusted knowledge and attitude barriers were used to identify that those who agreed CXRs were useful in managing bronchiolitis were more likely to order CXRs, and those who felt bronchodilators shortened length of stay were more likely to prescribe them. Concerns about ampicillin resistance and lack of confidence using local susceptibility patterns to guide prescribing were associated with ordering ceftriaxone. CONCLUSIONS: Provider-level factors and knowledge gaps were associated with ordering nonrecommended treatments for bronchiolitis and CAP.
BACKGROUND AND OBJECTIVES: Practice guidelines have been published for bronchiolitis and community-acquired pneumonia (CAP), but little is known about pediatricians' knowledge of and attitudes toward these guidelines since their publication. METHODS: We surveyed pediatric providers at 6 children's hospitals in the New York City area. Two vignettes, an infant with bronchiolitis and a child with CAP, were provided, and respondents were asked about management. Associations between respondent characteristics and their reported practices were examined using χ2 and Fisher's exact tests. Associations between questions probing knowledge and attitude barriers relevant to guideline adherence and reported practices were examined using Cochran-Mantel-Haenszel relative risk estimates. RESULTS: Of 283 respondents, 58% were trainees; 57% of attending physician respondents had finished training within 10 years. Overall, 76% and 45% of respondents reported they had read the bronchiolitis and CAP guidelines, respectively. For the bronchiolitis vignette, 40% reported ordering a chest radiograph (CXR), and 38% prescribed bronchodilators (neither recommended). For the CAP vignette, 38% prescribed ceftriaxone (not recommended). Study site, level of training, and practice locations were associated with nonrecommended practices. Site-adjusted knowledge and attitude barriers were used to identify that those who agreed CXRs were useful in managing bronchiolitis were more likely to order CXRs, and those who felt bronchodilators shortened length of stay were more likely to prescribe them. Concerns about ampicillin resistance and lack of confidence using local susceptibility patterns to guide prescribing were associated with ordering ceftriaxone. CONCLUSIONS: Provider-level factors and knowledge gaps were associated with ordering nonrecommended treatments for bronchiolitis and CAP.
Authors: Elizabeth R Wolf; Alicia Richards; Martin Lavallee; Roy T Sabo; Alan R Schroeder; Matthew Schefft; Alex H Krist Journal: Pediatrics Date: 2021-09-23 Impact factor: 9.703
Authors: Emily Allin; Nassr Nama; Michael A Irvine; Colleen Pawliuk; Marie Wright; Matthew Carwana Journal: BMJ Open Date: 2021-03-24 Impact factor: 2.692
Authors: Nicole M A Le Saux; Jennifer Bowes; Isabelle Viel-Thériault; Nisha Thampi; Julie Blackburn; Melanie Buba; Mary-Ann Harrison; Nick Barrowman Journal: Paediatr Child Health Date: 2020-06-30 Impact factor: 2.253